Tag: carcinoid blogs
![luncheon with the experts westchester April 3 2016](https://www.carcinoid.org/wp-content/uploads/2016/02/luncheon-with-the-experts-westchester-April-3-2016-300x300.jpg)
April Luncheon with the Experts in White Plains, NY — Carcinoid and Neuroendocrine Tumor Patients Are Invited!
The Big Apple NETs support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and 3 medical experts for Lunch with the Experts on Sunday, April 3, 2016 at 12:00 pm at the Westchester Hills Golf Club, 401 Ridgeway Avenue, …
READ MORE![Jonathan Strosberg on NETTER 1](https://www.carcinoid.org/wp-content/uploads/2016/01/Jonathan-Strosberg-on-NETTER-1-300x300.jpg)
Neuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium
Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…
READ MORE![2015 highlights](https://www.carcinoid.org/wp-content/uploads/2016/01/2015-highlights-300x300.jpg)
10 Highlights of the Year 2015 for the Carcinoid and Neuroendocrine Tumor Community
As we begin a new year, the Carcinoid Cancer Foundation looks back on the highlights of 2015 and to a future that we hope will bring greater awareness of carcinoid and neuroendocrine cancers, earlier diagnosis for patients, new treatment options, and …
READ MORE![jennifer chan md and matthew kulke md](https://www.carcinoid.org/wp-content/uploads/2015/11/jennifer-chan-md-and-matthew-kulke-md-300x300.jpg)
Neuroendocrine Tumors Focus of Upcoming Issue of Hematology/Oncology Clinics
Neuroendocrine Tumors will be featured in the February 2016 issue of Hematology/Oncology Clinics. Dr. Jennifer Chan and Dr. Matthew Kulke, both from Dana-Farber Cancer Institute in Boston, Massachusetts are Editors of the issue, published by Elsevier.…
READ MORE![Big Apple NETs 0](https://www.carcinoid.org/wp-content/uploads/2015/11/Big-Apple-NETs_0-300x223.jpg)
December Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Carcinoid and neuroendocrine tumor (NET) patients have a unique opportunity to hear from three medical experts during Lunch with the Experts in New York City on Sunday, December 6, 2015. This special program was initiated and is sponsored by the Big Apple…
READ MORE![crowne plaza hotel edison nj](https://www.carcinoid.org/wp-content/uploads/2015/09/crowne-plaza-hotel-edison-nj-300x300.jpg)
New Jersey Carcinoid/Neuroendocrine Cancer Conference in October, Registration Closing Soon
Two of the country’s leading carcinoid and neuroendocrine cancer specialists, a cardiologist with expertise in carcinoid heart disease, a registered dietitian who works regularly with the NET community, and a nurse practitioner with extensive…
READ MORE![thomas craig patterson 2](https://www.carcinoid.org/wp-content/uploads/2015/08/thomas-craig-patterson_2.jpg)
2nd Annual Tommyland Invitational Charity Golf Tournament, Utah
The 2nd Annual Tommyland Tourney, a charity golf tournament to benefit the Carcinoid Cancer Foundation, will be held on Sunday, September 13, 2015 at the Sun Hills Golf Course in Layton, Utah. The tournament is being held in memory of Thomas Craig Patterson…
READ MORE![Big Apple NETs 0](https://www.carcinoid.org/wp-content/uploads/2015/11/Big-Apple-NETs_0-300x223.jpg)
September Luncheon with the Experts in New York City — Carcinoid and Neuroendocrine Tumor Patients Are Invited!
Carcinoid and neuroendocrine tumor (NET) patients are invited to join three medical experts for Lunch with the Experts in New York City on Sunday, September 27, 2015 at 12:30 pm. This special program was initiated and is sponsored by the Big Apple NETs…
READ MORE![survey online feedback](https://www.carcinoid.org/wp-content/uploads/2015/08/survey-online-feedback-300x300.jpg)
New Survey for the Carcinoid and Neuroendocrine Tumor Community
The Carcinoid Cancer Foundation is always looking at ways of improving content and services available to people living with carcinoid cancer and other neuroendocrine tumors and we are working with a pharmaceutical partner, Ipsen, to better understand…
READ MORE![carcinoid syndrome lexicon pharmaceuticals telotristat etiprate clinical trial](https://www.carcinoid.org/wp-content/uploads/2015/08/carcinoid-syndrome-lexicon-pharmaceuticals-telotristat-etiprate-clinical-trial-300x300.jpg)
Lexicon’s Carcinoid Syndrome Treatment Meets Primary Endpoint in Phase III Clinical Trial
Lexicon Pharmaceuticals Inc. has announced that the pivotal phase III clinical trial, TELESTAR, of its oral drug candidate telotristat etiprate met the primary endpoint in treating cancer patients with carcinoid syndrome that is not adequately controlled…
READ MORE